Signifor approved for Cushing's disease
(HealthDay)—Signifor (pasireotide diaspartate) has been approved by the U.S. Food and Drug Administration to treat Cushing's disease in cases that cannot be treated by surgery.
Dec 17, 2012
0
0
(HealthDay)—Signifor (pasireotide diaspartate) has been approved by the U.S. Food and Drug Administration to treat Cushing's disease in cases that cannot be treated by surgery.
Dec 17, 2012
0
0
Scientists at the University of Liverpool have identified molecules in the blood that could help predict the risk of a patient developing liver injury eight hours after a paracetamol overdose.
Feb 22, 2013
0
0
Swiss pharmaceutical giant Novartis said Monday that it had reached a deal to buy US kidney treatment developer Chinook Therapeutics for up to $3.5 billion.
Jun 12, 2023
0
2
(HealthDay)—The anti-cancer drug Gleevec (imatinib) has received new U.S. Food and Drug Administration approval to treat the most common type of pediatric cancer, affecting some 2,900 children each year, the agency said ...
Jan 25, 2013
0
0
Swiss pharmaceutical giant Novartis said Sunday the expiry of a US patent for its leading hypertension drug Diovan caused a drop in turnover that could last into the first half of 2013.
Oct 7, 2012
0
0
A new strategy that cripples the ability of the dengue virus to escape the host immune system has been discovered by A*STAR's Singapore Immunology Network (SIgN). This breakthrough strategy opens a door of hope to what may ...
Aug 13, 2013
0
0
Swiss drug developer Novartis will team with technology giant Google to develop a "smart" contact lens that could improve some eye conditions or help diabetics manage their disease.
Jul 15, 2014
0
0
Federal health experts have unanimously endorsed a Novartis drug which is expected to become the first lower-cost copy of a biotech drug to reach the U.S. market.
Jan 7, 2015
0
10
Japan's health ministry said Friday it was probing claims falsified data was used in an Alzheimer's disease study involving major pharmaceutical firms, a day after filing an unrelated criminal complaint against Swiss drugs ...
Jan 10, 2014
0
0
Government regulators have approved a new pill from Novartis to treat heart failure, a deadly chronic disease that affects millions of U.S. patients.
Jul 7, 2015
0
6